sanofi Email Format
Pharmaceutical Manufacturing10001+ Employees
Sanofi is a global pharmaceutical manufacturer focused on discovering, developing and delivering therapies that address patients' needs. The company organizes its business around seven growth platforms, including rare diseases (through the Genzyme acquisition), vaccines, consumer healthcare, diabetes treatments, innovative medicines, emerging markets, and animal health. Listed in Paris and New York, the company operates with a broad international footprint across the healthcare landscape. Its products serve patients and health systems worldwide, spanning chronic and immune-related conditions. In mid-2026, regulatory authorities in the EU approved Cenrifki for secondary progressive multiple sclerosis without relapses, and Japan authorized Wayrilz for immune thrombocytopenia, signaling ongoing activity in its development pipeline.